TSSC3 Polyclonal Antibody

PHLDA2 (pleckstrin homology like domain family A member 2) is located in a cluster of imprinted genes on chromosome 11p15. , which is considered to be an important tumor suppressor gene region. Alterations in this region may be associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. PHLDA2 has been shown to be imprinted, with preferential expression from the maternal allele in placenta and liver.

The TSSC3 Polyclonal Antibody is a highly specific and sensitive antibody designed for use in various research applications. This antibody is produced using high-quality polyclonal antibodies that have been extensively validated for their specificity and sensitivity. The TSSC3 Polyclonal Antibody is ideal for use in immunohistochemistry, western blotting, and other applications where high sensitivity and specificity are required.

This antibody is designed to target TSSC3, a protein that is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis. The TSSC3 Polyclonal Antibody is highly specific and does not cross-react with other proteins, ensuring accurate and reliable results.

The TSSC3 Polyclonal Antibody is produced using state-of-the-art techniques and is rigorously tested to ensure its quality and consistency. This antibody is supplied in a convenient format and is ready to use in a variety of applications.

In summary, the TSSC3 Polyclonal Antibody is a highly specific and sensitive antibody that is ideal for use in various research applications. Its high specificity and sensitivity make it an excellent tool for studying TSSC3 and its role in various cellular processes. Its quality and consistency make it a reliable and convenient choice for researchers in the field.